fda halts glp-1 Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down compounding while @martymakary is photographed holding bootleg # Compound versions of GLP-1 drugs
Description
Cancers (Basel)

Country of Origin: USA Manufacturer/Importer/Packed By: Setymoy

CagriSema combines semaglutide with cagrilintide (an amylin analogue), targeting appetite through GLP-1R and amylin receptor pathways
To turn on Captions, click settings

Still, each one can lead to reduced persistence over time